These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1719459)

  • 1. Ultrasound detection of neural tube defects in patients with elevated maternal serum alpha-fetoprotein.
    Morrow RJ; McNay MB; Whittle MJ
    Obstet Gynecol; 1991 Dec; 78(6):1055-7. PubMed ID: 1719459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated maternal serum alpha-fetoprotein with normal ultrasound: is amniocentesis always appropriate? A review of 26,069 screened patients.
    Richards DS; Seeds JW; Katz VL; Lingley LH; Albright SG; Cefalo RC
    Obstet Gynecol; 1988 Feb; 71(2):203-7. PubMed ID: 2447540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound detection of fetal aneuploidy in patients with elevated maternal serum alpha-fetoprotein.
    Barth WH; Frigoletto FD; Krauss CM; MacMillin MD; Stryker JM; Benacerraf BR
    Obstet Gynecol; 1991 Jun; 77(6):897-900. PubMed ID: 1709481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of ultrasound and informed consent in the evaluation of elevated maternal serum alpha-fetoprotein.
    Katz VL; Seeds JW; Albright SG; Lingley LH; Lincoln-Boyea B
    Am J Perinatol; 1991 Mar; 8(2):73-6. PubMed ID: 1706599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The sensitivity of ultrasound and serum alpha-fetoprotein in population-based antenatal screening for neural tube defects. South Australia 1986-1991.
    Chan A; Robertson EF; Haan EA; Ranieri E; Keane RJ
    Br J Obstet Gynaecol; 1995 May; 102(5):370-6. PubMed ID: 7542023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prenatal diagnosis policy without routine amniocentesis in pregnancies with a positive family history for neural tube defects.
    Papp Z; Tóth Z; Török O; Szabó M
    Am J Med Genet; 1987 Jan; 26(1):103-10. PubMed ID: 2433941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early pregnancy screening for neural tube defects in Israel.
    Legum C; Shomrat R; Yedwab G; Jaffa AJ; Rudick A
    Isr J Med Sci; 1986; 22(3-4):210-4. PubMed ID: 2427475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maternal serum alpha-fetoprotein screening for the detection of neural tube defects.
    Crandall BF; Robertson RD; Lebherz TB; King W; Schroth PC
    West J Med; 1983 Apr; 138(4):524-30. PubMed ID: 6191442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Significance of the maternal levels of serum alpha-fetoprotein, human chorionic gonadotropin and unconjugated estriol in various congenital developmental defects in pregnancy trimester II].
    Kostiuk EV; Zolotukhina TV; Kuznetsov MI
    Genetika; 1992 Sep; 28(9):158-62. PubMed ID: 1282117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of ultrasound in evaluation of patients with elevated maternal serum alpha-fetoprotein: a review.
    Watson WJ; Chescheir NC; Katz VL; Seeds JW
    Obstet Gynecol; 1991 Jul; 78(1):123-8. PubMed ID: 1710797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results and benefits of a maternal serum alpha-fetoprotein screening program.
    Milunsky A; Alpert E
    JAMA; 1984 Sep; 252(11):1438-42. PubMed ID: 6206249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sensitivity and specificity of ultrasound for the detection of neural tube and ventral wall defects in a high-risk population.
    Lennon CA; Gray DL
    Obstet Gynecol; 1999 Oct; 94(4):562-6. PubMed ID: 10511359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parent preferences and prenatal testing for neural tube defects.
    Ennever FK; Lave LB
    Epidemiology; 1995 Jan; 6(1):8-16. PubMed ID: 7534119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A normal ultrasound does not obviate the need for amniocentesis in patients with elevated serum alpha-fetoprotein.
    Drugan A; Zador IE; Syner FN; Sokol RJ; Sacks AJ; Evans MI
    Obstet Gynecol; 1988 Oct; 72(4):627-30. PubMed ID: 2458560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The reliability of prenatal echographic studies of neural tube defects; a prospective study].
    Korenromp MJ; Kriek R; van den Born-van den Broek H; Stoutenbeek P; Bruinse HW
    Ned Tijdschr Geneeskd; 1993 Jun; 137(26):1298-302. PubMed ID: 7688447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated maternal serum alpha-fetoprotein values. How low is high?
    Lenke RR; Guerrieri J; Nemes JM; Kurczynski TW; French B; Gray M; Schut H; Ashwood ER
    J Reprod Med; 1989 Aug; 34(8):511-6. PubMed ID: 2478705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal diagnosis in diabetic gravidas: utility of ultrasound and maternal serum alpha-fetoprotein screening.
    Greene MF; Benacerraf BR
    Obstet Gynecol; 1991 Apr; 77(4):520-4. PubMed ID: 1706079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is MSAFP still a useful test for detecting open neural tube defects and ventral wall defects in the era of first-trimester and early second-trimester fetal anatomical ultrasounds?
    Roman AS; Gupta S; Fox NS; Saltzman D; Klauser CK; Rebarber A
    Fetal Diagn Ther; 2015; 37(3):206-10. PubMed ID: 25034077
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound-adjusted risk and spectrum of fetal chromosomal abnormality in women with elevated maternal serum alpha-fetoprotein.
    Megerian G; Godmilow L; Donnenfeld AE
    Obstet Gynecol; 1995 Jun; 85(6):952-6. PubMed ID: 7539525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound.
    Dashe JS; Twickler DM; Santos-Ramos R; McIntire DD; Ramus RM
    Am J Obstet Gynecol; 2006 Dec; 195(6):1623-8. PubMed ID: 16769022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.